| Literature DB >> 30889850 |
Zhijun Wu1,2, Xiaowei Wang3, Mo Chen4, Hongyan Hu5, Jie Cao6, Tuanyao Chai7,8, Hong Wang9.
Abstract
Polygonum cuspidatum Sieb. et Zucc. is a traditional Chinese herbal medicine widely used to treat tussis, hepatitis and arthralgia. This study identified and quantitatively described the bioactive compounds in different P. cuspidatum tissues. Metabolic profiles of root, stem, leaf, flower, rhizome and seed were determined using high-resolution mass spectrometry in combination with multivariate analyses. In total, 53 metabolites, 8 reported for the first time in this species, were putatively identified and classified mainly as stilbenes, anthraquinones and flavonoids. A principal component analysis, cluster analysis and heatmap were used to depict the correlations between specimens and the relative abundance levels of these compounds in different plant tissues. An orthogonal partial least square discriminant analysis found that 13 metabolites showed distinct differences among the six plant tissues, making them potential discriminative tissue-identification markers. This study will provide guidance in comparing, selecting and exploiting the medicinal uses of different P. cuspidatum tissues.Entities:
Keywords: LC-MS; Polygonum cuspidatum; metabolomics; multivariate analysis
Mesh:
Substances:
Year: 2019 PMID: 30889850 PMCID: PMC6471859 DOI: 10.3390/molecules24061058
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Principal component snalysis (PCA) and hierarchical cluster analysis on root, rhizome, leaf, flower, stem and seed groups. (a) Scores plot, (b) Loading plot, (c) Hierarchical cluster analysis of all samples. PCA and Hierarchical cluster analysis using all of the 4309 ion signals. Scores plot and loading plot of PCA model gives 2D visual information about the variations among different groups. Unsupervised PCA score plots showing the discrimination of samples. R2 = 0.741, Q2 = 0.621.
Characteristic fragment ions, retention times and m/z of metabolites tentatively identified based on reference standard, published literature, METLIN or HMDB database.
| Identification | Precursor Ion | Molecular Formula | Predicted | Measured | PPM | RT | ms2 Fragment Ions at Negative Mode | References |
|---|---|---|---|---|---|---|---|---|
| Tartaric acid | [M − H]− | C4H5O6 | 149.0086 | 149.0082 | 2.68 | 0.72 | 130.9882(2.3), 105.0215(5.60),103.0071(1.41), 87.0133(36.37), 72.9965(100) | HMDB, METLIN |
| Malic acid | [M − H]− | C4H5O5 | 133.0137 | 133.0133 | 3.01 | 0.72 | 115.0076(19.99), 89.0280(7.69), 72.9970(37.65), 71.0176(100),59.0163(7.95) | HMDB, METLIN |
| Citric acid | [M − H]− | C6H7O7 | 191.0192 | 191.0201 | 4.71 | 0.80 | 173.0125(3.75), 111.0125(100), 87.0126(65.85), 85.0336(76.01), 67.0217(21.87), 57.0419(17.03)103.0106 | HMDB, METLIN |
| Gallic acid | [M − H]− | C7H5O5 | 169.0215 | 169.0218 | 1.77 | 0.97 | 125.0284(100), 107.0178 (8.69), 111.0112(3.30), 97.0326(14.68), 79.0236(23.64), 69.0375(19.23) | Standard, METLIN |
| 6-Galloylglucose/2-Galloylglucose | [M − H]− | C13H15O10 | 331.0663 | 331.0664 | 0.30 | 1.14 | 241.0128(3.41), 211.0290(13.62), 169.0172(100), 151.0054(48.81), 137.0258(4.43),125.0263(43.17), 111.0117(17.48) | HMDB, [ |
| Salicylic acid beta- | [M − H]− | C13H15O8 | 299.0772 | 299.0775 | 1.00 | 1.34 | 225.0779(7.62), 179.0422(46.39), 137.0294(100), 119.0522(8.48), 93.0370(10.73), 73.0299(23.70),71.0166(26.89) | HMDB, METLIN |
| Epiafzelechin 3-gallate | [M − H]− | C22H17O9 | 425.0873 | 425.0861 | 2.82 | 2.23 | 407.0737(100), 255.0812(4.98), 151.0423(36.55), 137.0292(64.75), 125.0224(11.75) | HMDB |
| Epigallocatechin/Gallocatechin | [M − H]− | C15H13O7 | 305.0661 | 305.0672 | 3.61 | 2.31 | 219.0648(56.12), 191.0689(34.03), 167.0307(52.37), 139.0480(29.64), 137.0315(30.43), 125.0235(100), 111.0429(30.40) | HMDB, METLIN |
| Glucocaffeic acid | [M − H]− | C15H17O9 | 341.0873 | 341.0886 | 3.81 | 2.59 | 221.0438, 179.0379(100), 161.0244(6.52), 151.0395(11.84), 135.0485(33.41) | HMDB |
| Catechin | [M − H]− | C15H13O6 | 289.0712 | 289.0712 | 0.00 | 2.64 | 271.0601(5.61), 245.0827(23.84), 203.0720(53.62), 151.0424(28.46), 109.0320(100) | HMDB, Standard, [ |
| Chlorogenic acid | [M − H]− | C16H17O9 | 353.0852 | 353.0845 | 1.98 | 2.83 | 191.0585(100), 179.0378(5.08), 161.0270(2.69), 87.0068(2.1) | HMDB, METLIN, [ |
| Epigallate catechin gallate | [M − H]− | C22H17O11 | 457.0771 | 457.0759 | 2.63 | 2.93 | 303.0573(100), 287.0546(15.4), 169.0170(8.76), 165.0557(12.6) 161.0138(3.66), 151.0047(75.84), 125.0271(32.68) | HMDB, METLIN, |
| 3-p-Coumaroylquinic acid | [M − H]− | C16H17O8 | 337.0923 | 337.0931 | 2.37 | 3.29 | 277.0685(10.43), 231.0627(2.99), 191.0540(29.44), 173.0443(100), 163.0440(26.17), 119.0509(13.82) | HMDB |
| Epicatechin | [M − H]− | C15H13O6 | 289.0712 | 289.0707 | 1.73 | 3.59 | 289.0729(53.01), 245.0939(33.89), 221.0838(18.71), 203.0728(100), 151.0438(45.34), 123.0561(73.41), 109.0356(66.28) | HMDB, [ |
| Apigenin-6-glucoside 8-carabinoside | [M − H]− | C26H27O14 | 563.1395 | 563.1385 | 1.77 | 4.12 | 563.1375(100), 545.1283(3.52), 503.1142(7.92), 473.1088(10.53), 443.0946(12.11), 383.0897(10.82), 353.0642(10.79) | HMDB, [ |
| Procyanidin B1 | [M − H]− | C30H25O12 | 577.1346 | 577.1371 | 4.33 | 4.36 | 559.1370, 535.1225(23.27), 425.0878(38.95), 289.0731(100), 125.0276(54.62) | HMDB, [ |
| 3-galloylprocyanidin B1/B2 | [M − H]− | C37H29O16 | 729.1456 | 729.1429 | 3.70 | 4.42 | 603.1210(10.82), 577.1231(32.4), 441.0865(19.36), 407.0865(100), 289.0757(40.38), 271.0661(8.43), 125.0244(18.96) | HMDB, METLIN |
| Resveratrol-4′-o- | [M + COOH]- | C21H23O10 | 435.1286 | 435.1290 | 0.92 | 4.67 | 389.1263(2.05), 227.0733(100), 185.0636(1.17), 143.0524(0.64), | [ |
| Epicatechin gallate | [M − H]− | C22H17O11 | 441.0822 | 441.0809 | 2.95 | 4.69 | 303.0592(2.11),290.0796(14.52), 289.0770(47.78), 271.0629(7.1), 245.0826(8.03),169.0182(100), 151.0501(2.87), 125.0281(26.39) | HMDB, [ |
| Piceid | [M − H]− | C20H21O8 | 389.1240 | 389.1236 | 1.03 | 5.09 | 227.0723(100), 185.0687(5.44), 143.0526(1.28), | HMDB, METLIN, Standard, [ |
| Rutin | [M − H]− | C27H29O16 | 609.1456 | 609.1480 | 3.94 | 5.09 | 609.1493(100), 343.0538(1.34), 301.0387(16.57), 300.0319(25.44), 271.0245(1.43), 255.0305(0.78), 151.0107(0.63), | HMDB, METLIN, [ |
| Catechin gallate | [M − H]− | C22H17O10 | 441.0822 | 441.0809 | 2.95 | 5.23 | 303.0549(1.63), 289.0750(53.51), 245.0450(13.48), 205.0571(3.22), 169.0179(100), | HMDB, [ |
| Quercetin 4′-glucoside | [M − H]− | C21H19O12 | 463.0877 | 463.0859 | 3.87 | 5.30 | 343.0383(1.45), 301.0367(100), 283.0280 (1.21), 178.9999(6.03), 151.0080(2.21), 107.0185(0.65) | HMDB, METLIN |
| kaempferol galactoside | [M − H]− | C21H19O11 | 447.0922 | 447.0940 | 4.03 | 5.36 | 285.0455(100), 284.0392(17.21), 245.088(32.35) | HMDB, [ |
| Resveratrol-3-o-beta- | [M − H]− | C20H21O11S | 469.0799 | 469.0776 | 4.70 | 5.48 | 269.0746(4.56), 227.0669(8.43), 241.0073(100) | HMDB, [ |
| Quercetin xyloside | [M − H]− | C20H17O11 | 433.0771 | 433.0759 | 2.77 | 5.88 | 301.0384(100), 283.0242(1.57), 271.0315(11.66), 243.0355(1.93), 151.0068(5.46) | HMDB |
| Hydroxyl aloe-emodin-o-glucoside | [M − H]− | C21H19O9 | 447.0932 | 447.0949 | 3.80 | 6.03 | 241.0542(100), 403.1076(31.52), 197.0674(6.79), 161.0422(1.32) | [ |
| Resveratrol-3- | [M − H]− | C27H25O12 | 541.1341 | 541.1337 | 0.74 | 6.17 | 541.1337(100), 417.093(9.36), 313.0581(25.1), 227.0760(10.23), 169.0157(13.53) | [ |
| Procyanidin-B-1, 3-o-gallate | [M − H]− | C37H29O16 | 729.1450 | 729.1463 | 1.78 | 6.24 | 245.0816(19.85), 289.0719(59.57), 407.0833(100), 451.0952(26.42) | [ |
| Kaempferide | [M − H]− | C16H11O6 | 299.0556 | 299.0566 | 3.34 | 6.43 | 283.0082(4.81), 271.0251(6.79), 213.0597(100), 151.0082(17.20) | HMDB |
| Apigenin 7- | [M − H]− | C21H19O10 | 431.0978 | 431.0995 | 3.94 | 6.69 | 431.1004(100), 311.0561(0.65), 269.0497(92.44), 240.0466(10.54) | HMDB [ |
| Resveratrol | [M − H]− | C14H11O3 | 227.0708 | 227.0715 | 3.08 | 6.95 | 211.0384(6.59), 185.0640(100), 183.0846(10.63) 159.0824(11.21), 143.0506(80.26), 133.0355 | Standard, HMDB, METLIN, [ |
| Emodin-o-(sulfonyl)-glucoside | [M − H]− | C21H19O13S | 511.0541 | 511.0547 | 1.17 | 7.21 | 431.1007(100), 311.0631(1.68), 270.0539(12.13), 269.0485(41.04), 257.0494(1.03), 241.0040(4.82), 225.0545(0.82) | [ |
| Torachrysone 8-glucoside | [M − H]− | C20H23O9 | 407.1342 | 407.1353 | 2.70 | 7.86 | 245.0811(100), 269.0744(0.4) | METLIN, HMD, [ |
| Luteolin | [M − H]− | C15H9O6 | 285.0394 | 285.0387 | 2.46 | 8.04 | 285.0381(100), 267.0342(2.78), 257.0439(1.03),243.0279(1.84), 241.0489(2.14), 229.0493, 217.0488(3.9), 175.0381(5.29), 151.0031(11.51), 133.0329(18.27), 121.0273(0.73), 107.0162(3.31) | HMDB, METLIN, [ |
| Emodin-6-o-glucoside | [M − H]− | C21H19O10 | 431.0978 | 431.0982 | 0.93 | 8.14 | 431.1000(48.67), 311.0584(4.54), 293.0518(1.66), 282.0597(0.7), 269.0497(100), 225.0582(2.41), | HMDB, [ |
| Torachrysone-8-o-(sulfonyl)-glucoside | [M − H]− | C20H23O12S | 487.0905 | 487.0892 | 2.67 | 8.41 | 407.1355, 287.0927(1.03), 245.0841(100), 243.0051(8.32), 241.0076(90.07), 230.0601(7.32), 215.0435(0.55), 113.0251(1.32) | [ |
| Hydroxyl aloe-emodin | [M − H]− | C15H9O6 | 285.0394 | 285.0387 | 2.46 | 8.93 | 285.0401(100), 241.0543(2.17), 211.0421(0.34), 197.0586(0.69), 195.0533(0.4), 167.05(0.33), 151.0073(10.22), 133.0319(14.97), | HMDB, [ |
| 6″-Malonylgenistin | [M − H]− | C24H21O13 | 517.0982 | 517.0983 | 019 | 9.05 | 473.1056(100), 455.0952(0.53), 431.0968(2.51), 311.0553(3.47), 269.0454(75.44), 413.0835(0.25) | [ |
| Apigenin | [M − H]− | C15H9O5 | 269.0450 | 269.0449 | 0.37 | 9.10 | 269.0494(100), 241.0493(2.97), 227.0409(3.04), 225.0536(36.73), 151.0063(1.39), | METLIN, HMDB, [ |
| Apigenin 7- | [M − H]− | C23H21O11 | 473.1084 | 473.1086 | 0.42 | 9.15 | 473.1107(100), 431.0898(10.92), 413.0669(10.97), 311.0626(16.45), 269.0460(37.55), | HMDB |
| Bergapten | [M − H]− | C12H7O4 | 215.0344 | 215.0351 | 3.26 | 9.23 | 171.0469(2.83), 159.0484(100), 143.0535(18.1), 131.0531(86.87) | HMDB, METLIN |
| Torachrysone-8-o-(acetyl)-glucoside | [M − H]− | C22H25O10 | 449.1442 | 449.1439 | 0.45 | 9.24 | 269.0438(2.47), 245.0821(100), 230.0583(11.11), 215.0363(2.21), | [ |
| Acetylemodin-o-glucoside | [M − H]− | C23H21O11 | 473.1078 | 473.1073 | 1.06 | 9.54 | 335.9747(3.94), 311.0626(16.45), 283.0506(5.9), 269.0460(100), 267.07(12.37) | [ |
| Physcion-8-glucoside | [M − H]− | C22H21O10 | 445.1129 | 445.1145 | 3.59 | 9.71 | 325.0434(2.31), 283.0630(100), 240.0445(14.86), 165.0464(1.63), | [ |
| 6″- | [M − H]− | C24H23O11 | 487.1240 | 487.1240 | 0 | 11.35 | 283.0645(100), 267.0868(1.18) | HMDB |
| 6-hydroxylrhein | [M − H]− | C15H7O7 | 299.0186 | 299.0187 | 0.33 | 11.48 | 300.0192(32.33), 299.0193(100), 255.0328(16.88), 227.0381(6.13), 211.0423(12.13), 199.0473(1.99) | [ |
| Formononetin 7- | [M − H]− | C22H21O9 | 429.1186 | 429.1175 | 2.56 | 12.18 | 411.0650(7.35), 307.0586(7.87), 293.0452(100), 267.0667(21.06), 237.0614(6.34) | HMDB, METLIN |
| Acetylemodin | [M − H]− | C17H11O6 | 311.0551 | 311.0560 | 3.11 | 12.79 | 311.0563(100), 269.0429(14.3), 268.0402(48.88), 240.0466(3.84), 224.0481(1.22),196.0565(1.02) | [ |
| Apigenin 7-sulfate | [M − H]− | C15H9O8S | 349.0018 | 349.0034 | 4.58 | 12.81 | 331.2035(0.19), 306.3984(0.17), 269.0437(100), 241.0124(0.71), 227.0115(0.45) | HMDB, METLIN |
| Emodin | [M − H]− | C15H9O5 | 269.0450 | 269.0460 | 3.71 | 15.00 | 241.0512(21.33), 225.0546(100), 197.0626(1.11), 181.0666(1.33), 157.0626(0.39), 65.0044(0.14) | Standard, [ |
| Physcion | [M − H]− | C16H11O5 | 283.0606 | 283.0611 | 1.77 | 15.39 | 269.0381(24.64), 268.0362(100), 241.0456(8.91), 240.0412(21.34), 205.0512(13.4), 197.2618(1.65) | METLIN, [ |
Figure 2The proposed fragmentation pathways of selected compounds. (a) Piceid and resveratrol, (b) Acetylemodin-o-glucoside and emodin, (c) Luteolin, (d) Apigenin. The proposed fragmentation pathways were established based on generated fragment ions.
Figure 3Heatmap analysis of the relative distributions of 53 identified metabolites in different tissues. The heatmap was exhibited using a hierarchical clustering algorithm based on the normalized average signal abundance. The red and green color in the heatmap represent an increase and a decrease of metabolite level, respectively.
Figure 4OPLS-DA score plots and loading plots. (a) Score plots; (b) loading plots. The R2X, R2Y and Q2 values of OPLS-DA were 0.726, 0.987 and 0.973, respectively.
Figure 5The relative contents of thirteen markers in different tissues of P. cuspidatum. The contents of each compound was normalized as a relative content. The heatmap was exhibited using a hierarchical clustering algorithm based on the normalized average abundance.